AbbVie to Host Third-Quarter 2020 Earnings Conference Call

- October 6th, 2020

ABBVie will announce its third-quarter 2020 financial results on Friday, October 30, 2020 before the market opens. ABBVie will host a live webcast of the earnings conference call at 8 a.m. Central time . It will be accessible through ABBVie’s Investor Relations website investors.ABBVie.com . An archived edition of the session will be available later that day. About AbbVie AbbVie’s mission is to discover and deliver …

ABBVie (NYSE: ABBV) will announce its third-quarter 2020 financial results on Friday, October 30, 2020 before the market opens. ABBVie will host a live webcast of the earnings conference call at 8 a.m. Central time . It will be accessible through ABBVie’s Investor Relations website investors.ABBVie.com . An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on Twitter , Facebook , Instagram , YouTube and LinkedIn .

Cision View original content: http://www.prnewswire.com/news-releases/abbvie-to-host-third-quarter-2020-earnings-conference-call-301145010.html

SOURCE AbbVie

News Provided by PR Newswire via QuoteMedia

  Life Science and Healthcare Investing in 2020 report cover

Life Science and Healthcare Investing in 2020

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2020 life science outlook report!
 

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Tags

Tags:

Leave a Reply